axitinib,pembrolizumab
pfizer,merck
['kcsm,(-skcsm)', 'pembro', 'rcc,(-irccs),(-srcc),(-urcc)', 'kn-426', 'improve ', 'kn-564']
rapid fire #ccrcc discussion: 1) kn-564 adj pembro in resected #kcsm, 2) #1l axi + pembro kn-426 and 3) #1l len + pembro clear significantly improve #pfs2 compared to control with next-line #tki being most common agent on pd in #mrcc #asco22 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope